BerandaNATCOPHARM • NSE
add
Natco Pharma Ltd.
Tutup sebelumnya
₹1.374,75
Rentang hari
₹1.353,05 - ₹1.386,40
Rentang tahun
₹752,45 - ₹1.639,00
Kapitalisasi pasar
242,96 M INR
Volume Rata-Rata
534,22 rb
Rasio P/E
12,49
Hasil dividen
0,42%
Bursa utama
NSE
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 13,71 M | 32,94% |
Biaya operasional | 4,35 M | 8,42% |
Laba bersih | 6,77 M | 83,55% |
Margin laba bersih | 49,40 | 38,07% |
Penghasilan per saham | 37,81 | 83,54% |
EBITDA | 8,03 M | 75,44% |
Tarif pajak efektif | 17,32% | — |
Neraca
Total aset
Total liabilitas
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 24,63 M | 102,65% |
Total aset | 82,45 M | 31,83% |
Total liabilitas | 10,88 M | 13,26% |
Total ekuitas | 71,57 M | — |
Saham yang beredar | 179,13 jt | — |
Harga terhadap nilai buku | 3,44 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 27,91% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 6,77 M | 83,55% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. NATCO is a science driven company and focuses on limited competition molecules in the US. Wikipedia
Didirikan
1981
Kantor pusat
Situs
Karyawan
4.016
